Free Trial
TSE:CPH

Cipher Pharmaceuticals (CPH) Stock Price, News & Analysis

Cipher Pharmaceuticals logo
C$14.56 +0.48 (+3.41%)
As of 05/2/2025 04:00 PM Eastern

About Cipher Pharmaceuticals Stock (TSE:CPH)

Key Stats

Today's Range
C$14.12
C$14.80
50-Day Range
C$10.92
C$14.56
52-Week Range
C$8.01
C$19.69
Volume
28,428 shs
Average Volume
33,805 shs
Market Capitalization
C$261.40 million
P/E Ratio
16.08
Dividend Yield
N/A
Price Target
C$14.75
Consensus Rating
Moderate Buy

Company Overview

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

Receive CPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPH Stock News Headlines

Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
See More Headlines

CPH Stock Analysis - Frequently Asked Questions

Cipher Pharmaceuticals' stock was trading at C$14.32 at the start of the year. Since then, CPH shares have increased by 1.7% and is now trading at C$14.56.
View the best growth stocks for 2025 here
.

Cipher Pharmaceuticals Inc. (TSE:CPH) announced its quarterly earnings data on Thursday, August, 10th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.01. The company earned $7.10 million during the quarter, compared to analysts' expectations of $7.46 million. Cipher Pharmaceuticals had a net margin of 59.92% and a trailing twelve-month return on equity of 17.93%.
Read the conference call transcript
.

Shares of CPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cipher Pharmaceuticals investors own include Cipher Pharmaceuticals (CPHRF), Enbridge (ENB), Bellatrix Exploration (BXE), Crescent Point Energy (CPG), Manulife Financial (MFC), Surge Energy (SGY) and Toronto-Dominion Bank (TD).

Company Calendar

Last Earnings
8/10/2023
Today
5/03/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:CPH
Previous Symbol
TSE:DND
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$14.75
High Stock Price Target
C$17.00
Low Stock Price Target
C$12.50
Potential Upside/Downside
+1.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
16.08
Forward P/E Ratio
11.28
P/E Growth
N/A
Net Income
C$11.41 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$19.03 million
Cash Flow
C$4.13 per share
Price / Cash Flow
3.53
Book Value
C$3.96 per share
Price / Book
3.68

Miscellaneous

Free Float
N/A
Market Cap
C$261.40 million
Optionable
Not Optionable
Beta
1.20
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (TSE:CPH) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners